Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a ...
Me turns research into useful genetic insights, now offering a new GLP-1 report and interactive tool through 23andMe Total ...
A large 23andMe-based GWAS found that common variants in GLP1R and GIPR help explain why some people lose more weight or ...
Me Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies ...
Distinct GLP1R and GIPR variants correlated with nausea/vomiting risk, with a GIPR signal appearing tirzepatide-specific and showing markedly increased vomiting odds. New studies from 23andMe suggest ...
Type 1 diabetes is an autoimmune condition in which the body attacks its own insulin-producing cells in the pancreas. Some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results